Invest in Life
IVAO — reliable partner of investors, scientists, entrepreneurs and experts
in the world of biotechnology, pharmaceuticals and medicine
20
VITACOIN —
invest in your lifetime
For the first time in history you can buy anti-aging cure.
And it depends on you how soon it will be developed
And it depends on you how soon it will be developed
Know more
Thematic Investment Portfolios:
Explore the community —
IVAO is the best choice for those interested in comprehensive investments.
IVAO News
Get the most relevant news, establish new social connections and communicate with world-known experts.
As Biogen Inc. prepares to kick off earnings season Tuesday for a beaten-down large-cap biotechnology sector, investors won’t be too focused on the financial results.
Ziylo and Novo Nordisk A/S today announced that Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out company based at Unit DX science incubator in Bristol, UK. Ziylo has been pioneering the use of its platform technology - synthetic glucose binding molecules - for therapeutic and diagnostic applications.
The development, manufacture and sale of pharmaceutical drugs in the United States is a complex landscape involving intellectual property and strict federal regulations.
Apple Inc. unveiled the most-significant upgrades to the Apple Watch since it first went on sale in 2015, turning the product into more of a health monitoring device.
Events and Conferences
Database IVAO
The database presents the most promising opportunities for investing your capital.